(Q53985281)

23 May 2018

title

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). (English)

1 reference

23 May 2018

1 reference

1 reference

Y Lu

1

1 reference

23 May 2018

X Zi

2

1 reference

23 May 2018

Y Zhao

3

1 reference

23 May 2018

D Mascarenhas

4

1 reference

23 May 2018

M Pollak

5

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 December 2001

1 reference

23 May 2018

Journal of the National Cancer Institute

published in

1 reference

23 May 2018

volume

93

1 reference

23 May 2018

issue

24

1 reference

23 May 2018

page(s)

1852-1857

1 reference

23 May 2018

Untangling the ErbB signalling network

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Molecular targets for breast cancer therapy and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Receptor blockade with monoclonal antibodies as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

The role of the insulin-like growth factor I receptor in transformation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Regulation of survival signals from the insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

The insulin-like growth factor-binding protein (IGFBP) superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Proliferation, cell cycle and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Oncogenic kinase signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Signaling networks: the origins of cellular multitasking

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1852

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.24.1852

1 reference

23 May 2018

PubMed ID

11752009

1 reference

23 May 2018